BORG4_HUMAN - dbPTM
BORG4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BORG4_HUMAN
UniProt AC Q9H3Q1
Protein Name Cdc42 effector protein 4
Gene Name CDC42EP4
Organism Homo sapiens (Human).
Sequence Length 356
Subcellular Localization Endomembrane system
Peripheral membrane protein. Cytoplasm, cytoskeleton.
Protein Description Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation, when overexpressed in fibroblasts..
Protein Sequence MPILKQLVSSSVHSKRRSRADLTAEMISAPLGDFRHTMHVGRAGDAFGDTSFLNSKAGEPDGESLDEQPSSSSSKRSLLSRKFRGSKRSQSVTRGEREQRDMLGSLRDSALFVKNAMSLPQLNEKEAAEKGTSKLPKSLSSSPVKKANDGEGGDEEAGTEEAVPRRNGAAGPHSPDPLLDEQAFGDLTDLPVVPKATYGLKHAESIMSFHIDLGPSMLGDVLSIMDKEEWDPEEGEGGYHGDEGAAGTITQAPPYAVAAPPLARQEGKAGPDLPSLPSHALEDEGWAAAAPSPGSARSMGSHTTRDSSSLSSCTSGILEERSPAFRGPDRARAAVSRQPDKEFSFMDEEEEDEIRV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Methylation---MPILKQLVSSSV
---CCHHHHHHHCCH
42.1624129315
5Ubiquitination---MPILKQLVSSSV
---CCHHHHHHHCCH
42.16-
9PhosphorylationPILKQLVSSSVHSKR
CHHHHHHHCCHHHCC
26.0330266825
10PhosphorylationILKQLVSSSVHSKRR
HHHHHHHCCHHHCCC
28.9730266825
11PhosphorylationLKQLVSSSVHSKRRS
HHHHHHCCHHHCCCC
19.1523401153
14PhosphorylationLVSSSVHSKRRSRAD
HHHCCHHHCCCCHHH
26.2130266825
15UbiquitinationVSSSVHSKRRSRADL
HHCCHHHCCCCHHHH
36.63-
18PhosphorylationSVHSKRRSRADLTAE
CHHHCCCCHHHHHHH
35.5330266825
23PhosphorylationRRSRADLTAEMISAP
CCCHHHHHHHHHHCC
22.5630266825
28PhosphorylationDLTAEMISAPLGDFR
HHHHHHHHCCCCCCC
23.6423927012
42MethylationRHTMHVGRAGDAFGD
CCCEECCCCCCCCCC
34.02-
50PhosphorylationAGDAFGDTSFLNSKA
CCCCCCCCHHHCCCC
23.0429396449
51PhosphorylationGDAFGDTSFLNSKAG
CCCCCCCHHHCCCCC
32.2621815630
56UbiquitinationDTSFLNSKAGEPDGE
CCHHHCCCCCCCCCC
60.38-
64PhosphorylationAGEPDGESLDEQPSS
CCCCCCCCCCCCCCC
46.8019664994
68 (in isoform 2)Phosphorylation-42.7329743597
70PhosphorylationESLDEQPSSSSSKRS
CCCCCCCCCCHHHHH
42.4122167270
71PhosphorylationSLDEQPSSSSSKRSL
CCCCCCCCCHHHHHH
40.7122167270
72PhosphorylationLDEQPSSSSSKRSLL
CCCCCCCCHHHHHHH
42.8622167270
73PhosphorylationDEQPSSSSSKRSLLS
CCCCCCCHHHHHHHH
41.6522167270
74PhosphorylationEQPSSSSSKRSLLSR
CCCCCCHHHHHHHHH
33.7523927012
75UbiquitinationQPSSSSSKRSLLSRK
CCCCCHHHHHHHHHH
48.2121906983
76UbiquitinationPSSSSSKRSLLSRKF
CCCCHHHHHHHHHHH
34.19-
77PhosphorylationSSSSSKRSLLSRKFR
CCCHHHHHHHHHHHC
37.0829496963
80PhosphorylationSSKRSLLSRKFRGSK
HHHHHHHHHHHCCCH
38.4225137130
86O-linked_GlycosylationLSRKFRGSKRSQSVT
HHHHHCCCHHHCCCC
22.1930379171
89PhosphorylationKFRGSKRSQSVTRGE
HHCCCHHHCCCCCHH
30.4622617229
91PhosphorylationRGSKRSQSVTRGERE
CCCHHHCCCCCHHHH
27.0526329039
93PhosphorylationSKRSQSVTRGEREQR
CHHHCCCCCHHHHHH
37.9026434776
105PhosphorylationEQRDMLGSLRDSALF
HHHHHHHHHHHHHHH
19.1025463755
109PhosphorylationMLGSLRDSALFVKNA
HHHHHHHHHHHHHCC
22.0429255136
114UbiquitinationRDSALFVKNAMSLPQ
HHHHHHHHCCCCCCC
31.4921906983
118PhosphorylationLFVKNAMSLPQLNEK
HHHHCCCCCCCCCHH
34.1919664994
125UbiquitinationSLPQLNEKEAAEKGT
CCCCCCHHHHHHHCC
52.1321906983
138PhosphorylationGTSKLPKSLSSSPVK
CCCCCCHHHCCCCCE
31.3823927012
140PhosphorylationSKLPKSLSSSPVKKA
CCCCHHHCCCCCEEC
35.5422167270
141PhosphorylationKLPKSLSSSPVKKAN
CCCHHHCCCCCEECC
43.9130266825
142PhosphorylationLPKSLSSSPVKKAND
CCHHHCCCCCEECCC
30.2722167270
146UbiquitinationLSSSPVKKANDGEGG
HCCCCCEECCCCCCC
53.2921906983
159PhosphorylationGGDEEAGTEEAVPRR
CCCCCCCCCCCCCCC
37.3923312004
174PhosphorylationNGAAGPHSPDPLLDE
CCCCCCCCCCCCCCC
33.8525159151
188PhosphorylationEQAFGDLTDLPVVPK
CHHCCCCCCCCCCCC
39.9823927012
255PhosphorylationTITQAPPYAVAAPPL
CCCCCCCCEEECCCH
16.7922817900
275PhosphorylationKAGPDLPSLPSHALE
CCCCCCCCCCHHHHC
61.2823927012
278PhosphorylationPDLPSLPSHALEDEG
CCCCCCCHHHHCCCC
27.0423927012
292PhosphorylationGWAAAAPSPGSARSM
CCCCCCCCCCCCCCC
36.8522167270
295PhosphorylationAAAPSPGSARSMGSH
CCCCCCCCCCCCCCC
24.7222167270
298PhosphorylationPSPGSARSMGSHTTR
CCCCCCCCCCCCCCC
27.4920363803
301PhosphorylationGSARSMGSHTTRDSS
CCCCCCCCCCCCCCC
14.7120363803
303PhosphorylationARSMGSHTTRDSSSL
CCCCCCCCCCCCCHH
25.8128857561
304PhosphorylationRSMGSHTTRDSSSLS
CCCCCCCCCCCCHHC
27.3623403867
307PhosphorylationGSHTTRDSSSLSSCT
CCCCCCCCCHHCCCC
20.6629507054
308PhosphorylationSHTTRDSSSLSSCTS
CCCCCCCCHHCCCCC
39.3230266825
309PhosphorylationHTTRDSSSLSSCTSG
CCCCCCCHHCCCCCH
35.9026657352
311PhosphorylationTRDSSSLSSCTSGIL
CCCCCHHCCCCCHHH
25.8930266825
312PhosphorylationRDSSSLSSCTSGILE
CCCCHHCCCCCHHHH
27.0629978859
314PhosphorylationSSSLSSCTSGILEER
CCHHCCCCCHHHHCC
31.7529978859
315PhosphorylationSSLSSCTSGILEERS
CHHCCCCCHHHHCCC
28.3229978859
322PhosphorylationSGILEERSPAFRGPD
CHHHHCCCHHHCCCH
24.7030266825
344PhosphorylationRQPDKEFSFMDEEEE
CCCCCCCCCCCHHHH
22.2822617229

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
18SPhosphorylationKinasePKCAP17252
PSP
80SPhosphorylationKinasePKCAP17252
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BORG4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BORG4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
FAM9B_HUMANFAM9Bphysical
25416956
SEPT4_HUMANSEPT4physical
26186194
SEPT2_HUMANSEPT2physical
26186194
SEPT7_HUMANSEPT7physical
26186194
SEPT5_HUMANSEPT5physical
26186194
SEPT6_HUMANSEPT6physical
26186194
SEPT8_HUMANSEPT8physical
26186194
SEP11_HUMANSEPT11physical
26186194
SEPT9_HUMANSEPT9physical
26186194
SEPT3_HUMANSEPT3physical
26186194
KLH15_HUMANKLHL15physical
26186194
SEP10_HUMANSEPT10physical
26186194
YBEY_HUMANYBEYphysical
26186194
FHL2_HUMANFHL2physical
26186194
SEP10_HUMANSEPT10physical
28514442
SEPT3_HUMANSEPT3physical
28514442
SEPT8_HUMANSEPT8physical
28514442
SEPT5_HUMANSEPT5physical
28514442
SEPT2_HUMANSEPT2physical
28514442
SEPT6_HUMANSEPT6physical
28514442
SEPT7_HUMANSEPT7physical
28514442
SEP11_HUMANSEPT11physical
28514442
SEPT9_HUMANSEPT9physical
28514442
SEPT4_HUMANSEPT4physical
28514442
SEP14_HUMANSEPT14physical
28514442
FHL2_HUMANFHL2physical
28514442
KLH15_HUMANKLHL15physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BORG4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64; SER-138; SER-142;SER-174; SER-292 AND SER-295, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, ANDMASS SPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292 AND SER-295, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-142, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174; SER-292 ANDSER-295, AND MASS SPECTROMETRY.

TOP